We are live on ! Find out more
BSX icon

Boston Scientific

787 hedge funds and large institutions have $49B invested in Boston Scientific in 2019 Q1 according to their latest regulatory filings, with 100 funds opening new positions, 302 increasing their positions, 248 reducing their positions, and 51 closing their positions.

New
Increased
Maintained
Reduced
Closed

121% more call options, than puts

Call options by funds: $143M | Put options by funds: $64.6M

96% more first-time investments, than exits

New positions opened: 100 | Existing positions closed: 51

22% more repeat investments, than reductions

Existing positions increased: 302 | Existing positions reduced: 248

8% more funds holding

Funds holding: 730 → 787 (+57)

2% more capital inflows, than outflows

Capital inflows: $2.6B | Capital outflows: $2.56B

0.03% less ownership

Funds ownership: 91.95% → 91.92% (-0.03%)

25% less funds holding in top 10

Funds holding in top 10: 20 → 15 (-5)

Holders
787
Holders Change
+57
Holders Change %
+7.81%
% of All Funds
16.99%
Holding in Top 10
15
Holding in Top 10 Change
-5
Holding in Top 10 Change %
-25%
% of All Funds
0.32%
New
100
Increased
302
Reduced
248
Closed
51
Calls
$143​M
Puts
$64.6​M
Net Calls
+$78​M
Net Calls Change
-⁠$12​M

BSX Hedge Fund Activity: Q1 2019 in Review

787 of the 4,633 institutional investors tracked by Wall St. Rank reported a position in Boston Scientific (BSX) for Q1 2019, worth a combined $49B — up 9.1% from $45B a quarter earlier.

Buyers outnumbered sellers: 100 funds opened new BSX positions and 51 closed out — a net gain of 49 holders — while 302 added to existing stakes and 248 trimmed.

The largest buyer was Third Point, opening a new position worth an estimated $191M. The largest seller was Capital Research Global Investors, cutting an estimated $383M.

  • 787 institutional investors held Boston Scientific (BSX) as of Q1 2019, up from 730 in Q4 2018.
  • Funds reported $49B of Boston Scientific stock for Q1 2019, up 9.1% quarter-over-quarter.
  • 100 funds opened new Boston Scientific positions in Q1 2019 and 51 closed out, a net change of +49 holders.
  • The largest Boston Scientific buyer in Q1 2019 was Third Point, an estimated $191M added.
  • The largest Boston Scientific seller in Q1 2019 was Capital Research Global Investors, an estimated $383M sold.

Based on aggregated 13F filings for Q1 2019.